Literature DB >> 6528791

Lipids, lipoproteins and apolipoproteins in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus.

G Bittolo Bon, G Cazzolato, P Avogaro.   

Abstract

Total plasma cholesterol, triglycerides, VLDL-C, VLDL-TG, HDL-C and the apoproteins A-I, A-II, B and D were measured in 111 male non-obese diabetic patients and in 90 male control subjects of similar age and body weight distribution. Forty-eight patients had Type 1 (insulin-dependent diabetes) and 63 had Type 2 (non-insulin-dependent diabetes); all were in stable metabolic control while following an appropriate diet and therapy with insulin or oral hypoglycemic agents. HDL-C, apoA-I, apoB and the apoA-I/apoA-II ratio were significantly increased in the Type 1 patients, whereas the VLDL-C/VLDL-TG and LDL-C/apoB ratios were decreased significantly. Type 2 diabetics showed low HDL-C and low apoA-I/apoA-II ratio, while the values of apoA-I, A-II, D and the VLDL-C/VLDL-TG ratio were significantly higher than in controls. Type 1 diabetics in 'fair' metabolic control presented higher values of TG, VLDL-C, VLDL-TG and apoB than patients in 'good' control: lower values of apoA-I and of the ratios apoA-I/apoA-II, apoA-I/apoB and LDL-C/apoB were recorded in the same subgroup. In Type 2 diabetics no significant differences were observed according to metabolic control, with the exception of a higher apo-D value in subjects in 'fair' control. The data obtained support the view that good metabolic control may be important for the prevention of a relevant derangement of lipoprotein components, particularly in Type 1 patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6528791     DOI: 10.1007/bf02582084

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  43 in total

1.  Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control.

Authors:  A L Kennedy; T R Lappin; T D Lavery; D R Hadden; J A Weaver; D A Montgomery
Journal:  Br Med J       Date:  1978-10-28

2.  Variations in apolipoproteins B and A1 during the course of myocardial infarction.

Authors:  P Avogaro; G B Bon; G Cazzolato; G B Quinci; A Sanson; M Sparla; G C Zagatti; G Caturelli
Journal:  Eur J Clin Invest       Date:  1978-06       Impact factor: 4.686

3.  Polypeptide distribution of the main lipoprotein density classes separated from human plasma by rate zonal ultracentrifugation.

Authors:  G M Kostner; J R Patsch; S Sailer; H Braunsteiner; A Holasek
Journal:  Eur J Biochem       Date:  1974-06-15

4.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

Review 5.  Hyperglycemia. A risk factor in coronary heart disease.

Authors:  F H Epstein
Journal:  Circulation       Date:  1967-10       Impact factor: 29.690

6.  Relationship between apolipoproteins and chemical components of lipoproteins in survivors of myocardial infarction.

Authors:  P Avogaro; G B Bon; G Cazzolato; E Rorai
Journal:  Atherosclerosis       Date:  1980-09       Impact factor: 5.162

7.  High density lipoprotein composition in insulin-dependent diabetes mellitus.

Authors:  R H Eckel; J J Albers; M C Cheung; P W Wahl; F T Lindgren; E L Bierman
Journal:  Diabetes       Date:  1981-02       Impact factor: 9.461

8.  Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics.

Authors:  H J Lisch; S Sailer
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

9.  Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus.

Authors:  G D Calvert; J J Graham; T Mannik; P H Wise; R A Yeates
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  3 in total

1.  Apolipoprotein profile in type II diabetic patients with and without coronary heart disease.

Authors:  C M Barbagallo; M R Averna; S Amato; G Marino; M Labisi; A C Rao; M Barbagallo; G F Cupidi; A Notarbartolo
Journal:  Acta Diabetol Lat       Date:  1990 Oct-Dec

2.  Lipoprotein pattern in long-term diabetes of an at least 35 years' duration. Results of the Erfurt Study.

Authors:  U J Schauer; G Panzram; D Pissarek; K Rühling; L Winkler; R Lundershausen
Journal:  Klin Wochenschr       Date:  1988-08-01

3.  Metabolism of HDL apolipoprotein A-I and A-II in type 1 (insulin-dependent) diabetes mellitus.

Authors:  M R Taskinen; J Kahri; V Koivisto; J Shepherd; C J Packard
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.